Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Arranz-Alvarez, M."" wg kryterium: Autor


Wyświetlanie 1-7 z 7
Tytuł :
ΔNp73 status in peritoneal and ovarian dissemination of appendicular adenocarcinoids (goblet cells).
Autorzy :
Prieto-Nieto MI; Peritoneal Oncological Surgery Unit, Hospital La Paz, Madrid, Spain. .
Pastor D; Peritoneal Oncological Surgery Unit, Hospital La Paz, Madrid, Spain.
Rodríguez-Cobos J; Department of Medicine, Faculty of Medicine, Institute of Biomedical Research Alberto Sols, CSIC-UAM, Madrid, Spain.
Pérez JP; Peritoneal Oncological Surgery Unit, Hospital La Paz, Madrid, Spain.
Méndez C; Pathological Department, Hospital La Paz, Madrid, Spain.
Palacios E; Pathological Department, Hospital La Paz, Madrid, Spain.
Arranz-Alvarez M; Biobanco Idipaz, Hospital Universitario La Paz, Idipaz, Madrid, Spain.
Santos-López J; Department of Medicine, Faculty of Medicine, Institute of Biomedical Research Alberto Sols, CSIC-UAM, Madrid, Spain.
Cano-Vega M; Department of Medicine, Faculty of Medicine, Institute of Biomedical Research Alberto Sols, CSIC-UAM, Madrid, Spain.
Viñal D; Medical Oncology Department, Hospital La Paz, Madrid, Spain.
Rodríguez N; Medical Oncology Department, Hospital La Paz, Madrid, Spain.
Domínguez G; Department of Medicine, Faculty of Medicine, Institute of Biomedical Research Alberto Sols, CSIC-UAM, Madrid, Spain. .
Pokaż więcej
Źródło :
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2019 Oct; Vol. 21 (10), pp. 1432-1439.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Adenocarcinoma/*chemistry
Appendiceal Neoplasms/*chemistry
Biomarkers, Tumor/*analysis
Goblet Cells/*chemistry
Ovarian Neoplasms/*chemistry
Peritoneal Neoplasms/*chemistry
Tumor Protein p73/*analysis
Adenocarcinoma/secondary ; Adenocarcinoma/therapy ; Appendiceal Neoplasms/pathology ; Appendiceal Neoplasms/therapy ; Colon/chemistry ; Colonic Neoplasms/chemistry ; Cytoreduction Surgical Procedures ; Down-Regulation ; Female ; Humans ; Hyperthermia, Induced ; Male ; Middle Aged ; Ovarian Neoplasms/secondary ; Peritoneal Neoplasms/secondary ; Peritoneum/chemistry
Czasopismo naukowe
Tytuł :
Anti-CXCR4 Antibody Combined With Activated and Expanded Natural Killer Cells for Sarcoma Immunotherapy.
Autorzy :
Vela M; Translational Research in Pediatric Oncology, Hematopoietic Transplantation and Cell Therapy, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
Bueno D; Pediatric Hemato-Oncology Department, Hospital Universitario La Paz, Madrid, Spain.
González-Navarro P; Translational Research in Pediatric Oncology, Hematopoietic Transplantation and Cell Therapy, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
Brito A; Translational Research in Pediatric Oncology, Hematopoietic Transplantation and Cell Therapy, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
Fernández L; H12O-CNIO Hematological Malignancies Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Escudero A; Molecular Pediatric Oncology Unit, Institute of Medical and Molecular Genetics (INGEMM), La Paz University Hospital, Madrid, Spain.
Valentín J; Translational Research in Pediatric Oncology, Hematopoietic Transplantation and Cell Therapy, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
Mestre-Durán C; Translational Research in Pediatric Oncology, Hematopoietic Transplantation and Cell Therapy, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
Arranz-Álvarez M; Biobank of Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
Pérez de Diego R; Laboratory of Immunogenetics of Human Diseases, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.; Innate Immunity Group, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.; CIBER of Respiratory Diseases (CIBERES), Madrid, Spain.
Mendiola M; Molecular Pathology and Therapeutic Targets, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.; Molecular Pathology Section, Institute of Medical and Molecular Genetics (INGEMM), La Paz University Hospital, Madrid, Spain.
Pozo-Kreilinger JJ; Molecular Pathology and Therapeutic Targets, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.; Pathology Service, La Paz University Hospital, Madrid, Spain.
Pérez-Martínez A; Pediatric Hemato-Oncology Department, Hospital Universitario La Paz, Madrid, Spain.; Department of Pediatric, Universidad Aut ónoma de Madrid (UAM), Instituto de Investigaci ón Sanitaria del Hospital Universitario La Paz (IdiPAZ), Madrid, Spain.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2019 Aug 02; Vol. 10, pp. 1814. Date of Electronic Publication: 2019 Aug 02 (Print Publication: 2019).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Monoclonal/*immunology
Killer Cells, Natural/*immunology
Receptors, CXCR4/*immunology
Sarcoma/*immunology
Sarcoma/*therapy
Animals ; Cell Line, Tumor ; Cytotoxicity, Immunologic/immunology ; Female ; Humans ; Immunologic Factors/immunology ; Immunotherapy ; Immunotherapy, Adoptive/methods ; Lung Neoplasms/immunology ; Mice ; Mice, Inbred NOD ; Rhabdomyosarcoma/immunology ; Signal Transduction/immunology
Czasopismo naukowe
    Wyświetlanie 1-7 z 7

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies